PRECLINICAL ALZHEIMER'S DISEASE
Clinical trials for PRECLINICAL ALZHEIMER'S DISEASE explained in plain language.
Never miss a new study
Get alerted when new PRECLINICAL ALZHEIMER'S DISEASE trials appear
Sign up with your email to follow new studies for PRECLINICAL ALZHEIMER'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope in fight against Alzheimer's: Dual-Attack drug trial launches
Disease control Not yet recruitingThis clinical trial aims to test whether new drugs that target tau protein in the brain can slow Alzheimer's disease progression, either alone or combined with existing amyloid-targeting treatments. It will enroll 750 adults aged 50-80 who have early signs of Alzheimer's but mini…
Matched conditions: PRECLINICAL ALZHEIMER'S DISEASE
Phase: PHASE2 • Sponsor: Paul S. Aisen • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
New Alzheimer's vaccine trial aims to slow brain damage
Disease control Not yet recruitingThis study is testing a vaccine called AADvac1, designed to target a harmful protein called tau in the brain. It aims to see if the vaccine, given alone or with another Alzheimer's drug, can reduce tau buildup and slow disease progression in adults aged 50-80 with very early sign…
Matched conditions: PRECLINICAL ALZHEIMER'S DISEASE
Phase: PHASE2 • Sponsor: Paul S. Aisen • Aim: Disease control
Last updated Mar 05, 2026 13:59 UTC
-
First human test of Alzheimer's prevention vaccine begins
Prevention Not yet recruitingThis early-stage study aims to test the safety of an experimental vaccine called AV-1980R in older adults who show early biological signs of Alzheimer's disease but don't yet have memory problems. The study will enroll 48 participants aged 65-80 who will receive either the vaccin…
Matched conditions: PRECLINICAL ALZHEIMER'S DISEASE
Phase: PHASE1 • Sponsor: Institute for Molecular Medicine • Aim: Prevention
Last updated Apr 02, 2026 02:41 UTC